10/21/2025
4:43 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2025
11:22 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
09/30/2025
6:06 PM | MBX Biosciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
09/30/2025
5:15 PM | MBX Biosciences (Subject)
Norwest Venture Partners XVI, LP (Filed by)
| Form SCHEDULE 13D/A | |
09/30/2025
3:59 PM | FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2025
4:01 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
MBX Biosciences (Subject)
| Form SCHEDULE 13D/A | |
09/26/2025
3:01 PM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2025
3:03 PM | MBX Biosciences (Filer)
| Form 424B4 | |
09/24/2025
11:15 PM | MBX Biosciences (Filer)
| Form EFFECT | |
09/24/2025
7:19 PM | MBX Biosciences (Filer)
| Form S-1MEF | |
09/22/2025
3:12 PM | MBX Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for MBX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
09/22/2025
7:00 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2025
7:09 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2025
4:23 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
MBX Biosciences (Subject)
| Form SCHEDULE 13D/A | |
08/14/2025
7:48 AM | Deep Track Capital, LP (Filed by)
MBX Biosciences (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
9:34 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
7:46 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2025
7:10 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
7:02 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
6:59 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
10:29 AM | Mathers Edward T (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:59 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:03 AM | MBX Biosciences (Issuer)
Ryder Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:04 AM | CORNELIUS JAMES M (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:05 AM | Aynechi Tiba (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
6:59 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
7:01 AM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:02 AM | Heron Patrick J (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
9:44 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
7:11 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
7:19 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
7:43 AM | MBX Biosciences (Filer)
| Form DEF 14A | |
04/23/2025
7:45 AM | MBX Biosciences (Filer)
| Form DEFA14A | |
04/23/2025
7:46 AM | MBX Biosciences (Filer)
| Form ARS | |
04/10/2025
7:39 AM | MBX Biosciences (Issuer)
Pescovitz Ora H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
7:27 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
7:24 AM | Hoerter Steven L. (Reporting)
MBX Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2025
7:11 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:34 AM | MBX Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/17/2025
7:07 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:14 AM | MBX Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
02/19/2025
4:52 PM | MBX Biosciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
4:56 PM | GORDON CARL L (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Hawryluk P. Kent (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Bartram Richard (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:17 PM | Azoulay Salomon (Reporting)
MBX Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:21 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | MBX Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
11/07/2024
7:31 AM | MBX Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
7:08 AM | MBX Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:38 PM | Hawryluk P. Kent (Filed by)
MBX Biosciences (Subject)
| Form SC 13G | |
Free MBX Stock Alerts